Documente Academic
Documente Profesional
Documente Cultură
Overview of concept
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003 By: Alireza Khadem
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
WHO
SEARO
WHO
SEARO
WHO
SEARO
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
WHO
SEARO
Why GMP
Patients taking medicines have very little chance of detecting if anything is wrong If something is wrong it can be very dangerous The doctor, pharmacist and patient, all trust those who manufactured and packaged the product
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
WHO
SEARO
History of GMP
1930 Lubeck BCG Vaccine
251 vaccinated 72 deaths because of tuberculosis 135 developed clinical tuberculosis 44 survived
Thorough investigations following this incident, it become very probable that batches of the vaccine were contaminated with the so-called Kiel-strain
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
WHO
SEARO
History of GMP
1938 - Sulphanilamide, the elixir of death
FDCA-1938
The "miracle drug" came into use. It was marketed as a pediatric elixir. It was a raspberry flavoured solution in a liquid industrial solvent, etheylene glycol. Generally an elixir is designated as an alcohol based product, but this particular formulation was of dietheylene glycol. Upon ingestion, ethylene glycol was metabolized to oxalic acid.
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
WHO
SEARO
History of GMP
1962- Thalidomide
One enantiomer caused sedation which was the desired effect, while the other enantiomer caused devastating birth defects known as Phocomelia. Solution was to remove the undesired enantiomer by a validated purification process assured by Assay Validation. Again, GMP deficiency by not having adequate QA and QC programmes which could have answered assay validation. This led to guidelines on the development of New Stereoisomeric Drugs (1992) US FDA.
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
WHO
SEARO
History of GMP
1955 - Polio Vaccine (Cutter Labs, USA)
(Lambert, E.C., Medical Mistakes, Indiana University Press, 1978)
Batch release
Inconsistent viral inactivation process. Quick scale-up production without proper validation of inactivation step. Active live virus production process used heat inactivation step. For virus; scale-up of heat inactivation step may not have been sufficient.
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
WHO
SEARO
History of GMP
PIC-GMP EC-GMP FDA-cGMP FDA-Aseptic Processing FDA-GMP GMP Enforcement by German National Law
WH0-GMP
1968
1971
1978
1983
1985
1987
1989
WHO
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
SEARO
History of GMP
Revision to Annex 1 EC-GMP
WHO-Revised GMP WHO-GMP for Biological products PIC-Adapts GMP According to EC-GMP WHO-GMP for Sterile pharmaceuticals WHO-Guide for Inspection
WHO-Revised GMP
1992
1992
1992
1996
1997
2002
2003
WHO
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
SEARO
What is GMP?
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
WHO
SEARO
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
WHO
SEARO
Quality Management
Determines and implements the quality policy The basic elements are: an appropriate infrastructure or quality system encompassing the Procedures, Processes, and Resources the systematic actions necessary to ensure adequate confidence that a product (or service) will satisfy given requirements for Quality The totality of these actions is termed Quality Assurance
WHO
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
SEARO
Quality management is defined as the aspect of management function that determines and implements the quality policy. The quality policy is a statement by the top management of the company of its overall intentions and direction relating to quality, formally expressed as a corporate policy.
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
WHO
SEARO
Quality Management
Terminology may differ Quality System is said to be rarely used in drug manufacturing
The concepts of QA, GMP and Quality Control are interrelated aspects of Quality Management. They are described on the following slides in order to emphasize their relationship and their fundamental importance to the production and control of pharmaceutical products
WHO
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
SEARO
There are two basic elements of this aspect of the management function of a pharmaceutical company:
A working infrastructure = quality system. This includes:
Organizational structure Procedures Processes Resources
Systematic actions to bring the quality policy to life. The totality of these actions is termed quality assurance (QA).
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
WHO
SEARO
Quality Relationships
Quality Objective Quality Manual Sampling Specifications Testing Personnel Training Validation Self inspection
Quality Control
GMP
Quality Assurance
Quality Management
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
WHO
SEARO
WHO
SEARO
QA is not the duty of one organizational unit in the company alone, but is the responsibility of all staff members who in any way can influence product quality.
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
WHO
SEARO
Requirements for QA Systems I 1. 2. 3. 4. Ensure products are developed correctly Identify managerial responsibilities Provide SOPs for production and control Organize supply and use of correct starting materials 5. Define controls for all stages of manufacture and packaging
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
WHO
SEARO
6. Ensure finished product correctly processed and checked before release 7. Ensure products are released after review by authorized person 8. Provide storage and distribution 9. Organize self-inspection
WHO
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
SEARO
GMP
Ensure that products are consistently produced and controlled Diminishes risks that cannot be controlled by testing of product
Cross-contamination Mix-ups
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
WHO
SEARO
that part of quality assurance which ensures that products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by the marketing authorization
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
WHO
SEARO
Quality Standards
DRA
NRA
NCL
Pharmacopeias
Inspection
Marketing Authorization
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
WHO
SEARO
WHO
SEARO
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
WHO
SEARO
Equipments
Premises
Validated Processes
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
WHO
SEARO
Each holder of a manufacturing authorization should have a QC Department Independence from production and other departments is considered to be fundamental Under the authority of an appropriately qualified and experienced person with one or several control laboratories at his or her disposal.
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
WHO
SEARO
Resources
Adequate facilities Trained personnel Approved procedures
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
WHO
SEARO
Tasks
Sampling Inspecting Testing Monitoring Releasing/rejecting
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
WHO
SEARO
Objects
Starting materials Packaging materials Intermediates Bulk products Finished products Environmental conditions
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
WHO
SEARO
WHO
SEARO
Basic Requirements for Quality Control III 7. 8. 9. 10. Ingredients are of the required purity Proper containers Correct labelling Release of batches by the authorized person 11. Retained samples of starting materials and products
WHO
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
SEARO
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
WHO
SEARO
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
WHO
SEARO
Other Issues
GLP GEP GCP GSP GDP
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
WHO
SEARO
Case study
WORKSHOP ON GOOD MANUFACTURING PRACTICES (GMPs) INSPECTION FOR VACCINES HYDERABAD, 10-18 NOVEMBER 2003
WHO
SEARO